Document Detail


Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
MedLine Citation:
PMID:  20446957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Reversible posterior leucoencephalopathy syndrome is a neurological condition seen in various areas of acute medicine, including the administration of antineoplastic therapies used in haemato-oncology patients. It is a rare complication that has been increasingly recognized. It is characterized by altered mental status, visual disturbance, headache and seizures. Magnetic resonance imaging typically shows vasogenic oedema in the posterior regions of the brain. Although its name suggests reversibility, it may result in an irreversible brain injury without prompt treatment. Therefore, it is vital for treating clinicians to recognize this syndrome. We describe the case of a 55-year-old woman with advanced pancreatic adenocarcinoma, who developed clinical and radiological manifestations consistent with this syndrome as a complication of gemcitabine monotherapy.
Authors:
C H Han; M P Findlay
Related Documents :
25022357 - Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage ...
24504587 - Diagnostic imaging of the mueller-weiss syndrome: findings of a rare condition of the f...
24811427 - Chilaiditi's syndrome associated with colonic volvulus and intestinal malrotation-a rar...
25117397 - Treatment with acarbose in severe hypoglycaemia due to late dumping syndrome.
24790647 - Experience in the use of clobazam in the treatment of lennox-gastaut syndrome.
25112827 - Fanconi syndrome and severe polyuria: an uncommon clinicobiological presentation of a g...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Internal medicine journal     Volume:  40     ISSN:  1445-5994     ISO Abbreviation:  Intern Med J     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-05-07     Completed Date:  2011-01-18     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  101092952     Medline TA:  Intern Med J     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  153-9     Citation Subset:  IM    
Affiliation:
Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / adverse effects*
Deoxycytidine / adverse effects,  analogs & derivatives*
Female
Humans
Middle Aged
Posterior Leukoencephalopathy Syndrome / chemically induced*,  diagnosis*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phaeochromocytoma-associated critical peripheral ischaemia.
Next Document:  Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to...